Table 1 Association between SH3BGRL expression and the clinical features in 1075 breast cancer patients
| Â | Â | Expression | Â | |
|---|---|---|---|---|
Variables | Cases (%) | High | Low | P value |
Gender | ||||
 Female | 1063 (98.9%) | 218 (20.5%) | 845 (79.5%) | 0.74 |
 Male | 12 (1.1%) | 2 (16.7%) | 10 (83.3%) |  |
Status | ||||
 Alive | 923 (85.9%) | 177 (19.2%) | 746 (80.8%) | 0.01 |
 Dead | 152 (14.1%) | 43 (28.3%) | 109 (71.7%) |  |
Age (Years) | ||||
  ≥ 50 | 775 (72.1%) | 170 (21.9%) | 605 (78.1%) | 0.143 |
  < 50 | 286 (26.6%) | 47 (16.4) | 239 (83.6%) |  |
 unknown | 14 (1.3%) | 3 (21.4%) | 11 (78.6%) |  |
Stage | ||||
 I | 89 (8.3%) | 19 (21.3%) | 70 (78.7%) | 0.17 |
 Ia | 86 (8.0%) | 24 (27.9%) | 62 (72.1%) |  |
 Ib | 5 (0.5%) | 0 (0.0%) | 5 (100.0%) |  |
 II | 6 (0.6%) | 0 (0.0%) | 6 (100.0%) |  |
 IIa | 352 (32.7%) | 82 (23.3%) | 270 (76.7%) |  |
 IIb | 251 (23.3%) | 41 (16.3%) | 210 (83.7%) |  |
 III | 2 (0.2%) | 0 (0.0%) | 2 (100.0%) |  |
 IIIa | 153 (14.2%) | 32 (20.9%) | 121 (79.1%) |  |
 IIIb | 25 (2.3%) | 4 (16.0%) | 21 (84.0%) |  |
 IIIc | 63 (5.9%) | 12 (19.0%) | 51 (81.0%) |  |
 IV | 20 (1.9%) | 2 (10.0%) | 18 (90.0%) |  |
 X | 11 (1.0%) | 0 (0.0%) | 11 (100%) |  |
 unknown | 12 (1.1%) | 4 (20.5%) | 8 (79.5%) |  |